leisure time -WSS

leisure time

author：leisure time 2025-09-30 18:17:07 - browse：9789

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending its shares up in early trading.

The drug, a once-weekly injection known as CT-388, resulted in an average placebo-adjusted weight loss of 18.8% after 24 weeks, the company said. The study was a Phase 1 trial, though it was placebo-controlled.

The reaction to such an early result — Roche shares were up roughly 4% early Thursday — is a signal both of the stakes of the obesity medication race and the keen interest investors have in the field.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Why 40% Americans with Parkinson’s don’t see a neurologist

hotspot

WSS

Medicare drug price negotiation program allowed for now

Would Medicare drug price negotiations stall in a shutdown?

What to know about OceanGate, the company behind the missing Titanic submersible

Medicaid, Medicare dual

Petition to FDA: Get the lead out of consumer hair dyes

HCA discloses massive data breach affecting 11 million patients

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Medicare proposal to cover medical devices draws a mixed reaction

N.Y. state detects polio case, first in the U.S. since 2013

In age of alternative facts, a scholarly course on calling out crap

Elizabeth Holmes on track for early release from her 11

DIEP, the 'gold standard' of breast reconstruction, is under threat

WHO recommends dropping component of many flu vaccines

As demand for Covid shots wanes, Moderna seeks its next success

HCA discloses massive data breach affecting 11 million patients

focus

Study: Pain burden is higher in Black NFL players than white ones

Inequities make cancer less preventable for women: report

Researchers use wearables data and AI to predict preterm birth risk

Oak trusses raised to roof of fire

Health tech startups drop sharply from 2021 highs

Beach reads and more: STAT's 2023 summer book list

hotspot

Wikipedia

hotspot

knowledge